• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

INmune Bio Inc. - Common stock (NQ:INMB)

1.830 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,760
Open 1.830
Bid (Size) 1.830 (3)
Ask (Size) 1.950 (11)
Prev. Close 1.830
Today's Range 1.830 - 1.830
52wk Range 1.710 - 11.64
Shares Outstanding 17,703,692
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025
Today 7:00 EDT
From INmune Bio, Inc.
Via GlobeNewswire
INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer’s Disease to npj Dementia, a Nature Portfolio Journal
September 29, 2025
From INmune Bio, Inc.
Via GlobeNewswire

Performance

YTD
-62.9%
-62.9%
1 Month
-7.1%
-7.1%
3 Month
-13.7%
-13.7%
6 Month
-75.8%
-75.8%
1 Year
-64.0%
-64.0%

More News

Read More
INmune Bio Announces Successful Completion of First Commercial Pilot-Scale Manufacturing Run of CORDStrom™ at CGT Catapult
September 15, 2025
From INmune Bio, Inc.
Via GlobeNewswire
Earnings Scheduled For August 7, 2025
August 07, 2025
Via Benzinga
INmune Bio (INMB) Q2 Loss Widens 110%
August 07, 2025
Via The Motley Fool
Topics Intellectual Property
12 Health Care Stocks Moving In Thursday's After-Market Session
August 07, 2025
Via Benzinga
What's going on in today's pre-market session
August 04, 2025
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 04, 2025
Via Benzinga
INmune Bio’s CaRe PC Trial of INKmune™ in Metastatic Castration-Resistant Prostate Cancer Meets Endpoints and Is Closed to Enrollment
August 04, 2025
From INmune Bio, Inc.
Via GlobeNewswire
INmune Bio Inc. to Report Second Quarter 2025 Financial Results and Provide Corporate Update on Thursday, August 7th
July 31, 2025
From INmune Bio, Inc.
Via GlobeNewswire
INmune Bio to Publish Video Detailing MINDFuL Trial Findings of XPro™ Presented at the Alzheimer’s Association International Conference
July 29, 2025
From INmune Bio, Inc.
Via GlobeNewswire
Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
July 28, 2025
Via Benzinga
INmune Bio Rebounds Sharply During After Hours Trading: What's Driving the Surge?
July 28, 2025
Via Benzinga
INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer’s Association International Conference
July 24, 2025
From INmune Bio, Inc.
Via GlobeNewswire
'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday
July 04, 2025
Via Benzinga
Which stocks have an unusual volume on Thursday?
July 03, 2025
Via Chartmill
This Textron Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
July 01, 2025
Via Benzinga
INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
June 30, 2025
From INmune Bio, Inc.
Via GlobeNewswire
Let's take a look at the stocks that are in motion in today's session.
June 30, 2025
Via Chartmill
Crude Oil Moves Lower; Joby Aviation Shares Surge
June 30, 2025
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 30, 2025
Via Benzinga
Which stocks are moving on Monday?
June 30, 2025
Via Chartmill
Alzheimer's Setback Hits INmune Bio Stock, But FDA Hopes Remain
June 30, 2025
Via Benzinga
Dow Gains Over 100 Points; Chicago PMI Weakens In June
June 30, 2025
Via Benzinga
Topics Stocks
Gapping stocks in Monday's session
June 30, 2025
Via Chartmill

Frequently Asked Questions

Is INmune Bio Inc. - Common stock publicly traded?
Yes, INmune Bio Inc. - Common stock is publicly traded.
What exchange does INmune Bio Inc. - Common stock trade on?
INmune Bio Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for INmune Bio Inc. - Common stock?
The ticker symbol for INmune Bio Inc. - Common stock is INMB on the Nasdaq Stock Market
What is the current price of INmune Bio Inc. - Common stock?
The current price of INmune Bio Inc. - Common stock is 1.830
When was INmune Bio Inc. - Common stock last traded?
The last trade of INmune Bio Inc. - Common stock was at 10/13/25 04:00 PM ET
What is the market capitalization of INmune Bio Inc. - Common stock?
The market capitalization of INmune Bio Inc. - Common stock is 32.40M
How many shares of INmune Bio Inc. - Common stock are outstanding?
INmune Bio Inc. - Common stock has 32M shares outstanding.
Recent Quotes
View More
Symbol Price Change (%)
GOOG  244.64
+0.00 (0.00%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap